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ABSTRACT 
The concept of co-processing as a particle engineering technique continues to be used as a tool to enhance the functionality of several existing 
excipients. This important research was designed to improve the functionality of lactose monohydrate as excipient for direct compression by 
co-processing with microcrystalline cellulose. Microwave induced diffusion technique was first utilized for manufacturing Co processed lactose 
monohydrate (LM) - microcrystalline cellulose (MC) composites. The objective of the research was to obtain synergistic effects, incorporating 
better tablet adherence and hardness capacity. Box-Behnken experimental design was worked out to optimize the proportion of the primary 
excipients for the co-processed excipient. Fifteen experiments were carried out to assess the effect of primary excipients and mixing time 
required to prepare a slurry for microwaving treatment on percent fines, angle of repose, Carr’s index, friability, tensile strength, disintegration 
time as responses. The combination of the co-processed excipient that constructed significant characteristics after optimization was observed 
to be 70 % alpha-Lactose-monohydrate and 30 % microcrystalline cellulose. Consequently, Microcrystalline Cellulose-Lactose composites 
(MCLM), a co-processed excipient, were developed that offers functionality for direct compression, as a result of given flowability and 
compactability. Solid-state characterization was performed on optimized composites to ascertain its particle size, shape, distribution, surface 
morphology, degree of crystallinity, hygroscopicity, compatibility etc. employing proven analytical methods. Powder characteristics were 
determined by bulk and tapped densities, angle of repose, porosity, lubricant sensitivity ratio, dilution potential etc. The compaction patterns of 
MCLM were assessed employing Heckel and Kawakita equations and the compressibility, tabletability, compactability (CTC) profile was 
determined compared to the physical mixture of the native excipients and Cellactose. Tablets were developed by direct compression using 
paracetamol as the drug of choice. The results imply that microwave generated MCLM composites offers improved properties in c omparison 
with native MC and LM. The current study highlights the concept of microwave drying technique as a cost-effective means for manufacturing 
multifunctional directly compressible excipient in comparison to the spray-drying technique. 
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1. INTRODUCTION 
Throughout the last centuries tablet manufacturers have got 
the materials and processes which could generate 
compressed tablets comprising an accurate amount of an 
active pharmaceutical ingredient (API) at fairly low cost and 
high speed. The expansion with regards to actives, excipients 
and then tableting machines during the past years has 
transformed tablet production a science and the tablets 
among the most widely used dosage form [1, 2]. The 
simplicity of manufacturing, comfort and ease in 
administration, right dosing, and stability in comparison 
with oral liquids, tamper-proof compared to capsules, 
harmless in contrast to parental dosage forms helps it be a 
preferred and convenient dosage form. Professionals in the 
field of tableting are aware using the primary skill of 
tableting by three well-known techniques, i.e. Wet, dry 
granulation and direct compression. The advantages and 
disadvantages of wet granulation and dry granulation are 
very well described in the literature [3-5]. 
Direct compression is definitely the easiest and the cheapest 
technique by which tablets are developed straight from a 
mixture of the actives with the appropriate excipients. In 
wet granulation, the actives plus the excipients are blended 
with a wet binder to make an aggregate that could be 
consequently dried and passed through sieves in order to 
create granules of suitable size pertaining to the tableting 
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process [6]. During the dry granulation, the drug and the 
excipients are blended and afterwards passed through 
rollers and consequently screened for getting granules in 
appropriate sizes [7].  
Amongst all of the aforementioned techniques, direct 
compression is considered the most suitable as it needs only 
some unit operations, offers lesser energy consumption and 
it provides a lot better stability intended for moisture, 
oxidation, and temperature sensitive drugs [8]. 
Nevertheless, approximately 80 % among the tablet 
formulations are manufactured by means of wet granulation. 
This is certainly the consequence of the indigent mechanical 
properties demonstrated by several drugs [9]. An excellent 
excipient designed for direct compression applications 
ought to have the subsequent attributes: excellent 
compressibility, good flow, resistance from segregation, 
quick disintegration, low level of sensitivity to lubricants, 
scaling-up feasibility, and good dilution potential [10]. 
The strain of formulating poorly compressible drugs right 
into robust tablets by DC is usually borne mainly through 
excipients utilized for this operation. Most of these 
excipients comprise a larger proportion of any DC excipient 
in accordance with API. It has consequently led to a greater 
thrust to formulate high-functionality excipients suitable for 
DC formulations. Through the years, research in regards to 
excipient development has concentrated around the co-
processing of existing excipients to get a novel excipient 
with superior functionality. Co-processing of excipients is 
actually a particle engineering technique involving a 
combination of a couple of excipients at a sub - particle level 
intended to physically enhance their particular properties in 
a fashion that may not be accomplished through regular 
physical mixing [11, 12]. The final product with this 
technique contributed to the emergences of a composite 
excipient with improved functionalities like compressibility, 
flowability, dilution potential etc. [13]. A mixture of plastic 
and brittle deforming materials constitutes a co-processed 
excipient with the desired characteristics intended for 
tableting [14]. A large number of co-processing strategies 
have already been exercised, incorporating spray drying [13, 
15, 16], co-drying [16-18] wet massing, melt extrusion, 
spheronisation [19], co-precipitation [20], co-grinding [21, 
22] wet-, dry– and spray-granulation [23] and co-processing 
by crystal coating [24]. 
Innovative grades of known excipients may be obtained 
simply by transforming the powder fundamental properties 
resulting in improved derived (functional) properties. 
Fundamental attributes, such as particle size, shape, 
morphology, surface area, porosity and density, decide on 
excipient functional properties such as flowability, 
compressibility, compactibility, dilution potential, 
disintegration time and lubricant sensitivity.  However, 
functionality could be improved to a certain degree as a 
result of limited range of possible alterations [13]. New 
mixtures of existing excipients could be an interesting 
strategy to improve excipient functionality as almost all 
formulations consist of multiple excipients. Various feasible 
combinations of existing excipients can often achieve the 
required set of performance attributes. Still, the 
development of many of these combinations is a complicated 
process since one excipient might hinder the present 
functionality of another excipient [11]. Currently there are 
diversified commercial Multifunctional Pharmaceutical 
excipients are available just like Ludipress (Co processed 
milk sugar, PVP), Panexea (Co processed MCC, HPMC and 
CPVD), Provosolv ODT (Co processed Microcystalline 
polysaccharide, mixture silica, Mannitol, Fructose, 
Crospovidone) etc. Reveals improved functionality.[25] 
Lactose monohydrate (LM) and microcrystalline cellulose 
(MC) are widely used functional excipients utilized in solid 
dosage forms. The two are naturally produced and widely 
used in the pharmaceuticals, either independently or 
together. Due to the inherent compactability attributes, 
microcrystalline cellulose (MCC) is widespread as an 
excipient in tablet formulations. Good binder and 
disintegration characteristics are attained with 
microcrystalline cellulose when employed in directly 
compressed tablet formulations [23]. On the other hand, 
microcrystalline cellulose, often has lubricating sensitivity. 
Lubricant sensitivity pertains to the decrease in the bonding 
between the plastically-deforming particles inside the 
powder containing lubricant, that leads to lowering of tablet 
strength or hardness [26]. In the pharmaceutical 
manufacturing, lactose is among the most frequently used 
excipients; however, just like many other excipients, lactose 
might not be well suited for direct compression as a result of 
inadequate powder flow or compaction characteristics [27]. 
To formulate synergistic functional performance of lactose 
monohydrate and microcrystalline cellulose, including 
improved compactability and powder flow, LM and MC were 
co-dried utilizing microwave induced diffusion, resulting in a 
monoparticulate system developing two compaction 
mechanisms, brittle fracture and plastic deformation, in 
discrete particles. Current excipient provides the flow and 
compaction properties intended for direct compression 
tableting. Optimized composition comprises 70 % alpha-
lactose monohydrate and 30 % microcrystalline cellulose 
(MCC), each of those preserving their individual chemical 
identities. The excellent compactability of the material is 
produced by the synergic effect of consolidation by 
fragmentation of lactose as well as the plastic deformation of 
cellulose. While microwave drying, lactose particles cover 
the cellulose fibers developing granules of good flow. This 
unique excipient combines the good flowability and 
solubility of lactose together with the good water sorption 
and binding characteristics of cellulose [13]. 
Numerous procedures continue to be presented for 
synthesizing Multifunctional pharmaceutical excipients 
which include chemical modification, Physical modification, 
Grinding or sieving, Crystallization, Spray drying, 
Granulation/agglomeration and Dehydration [25]. Every 
single technique enlisted possesses its own benefits and 
drawbacks. Among all spray drying is a widespread 
approach to generate multifunctional excipients. Spray 
Drying produce highly porous particles with better flow and 
tabletability resulting in shorter time of disintegration inside 
the physiological fluids. Spray drying technology, is actually 
an expensive technique and also, it’s a time intensive process 
which usually produces less material. In current research 
attempts had been made to conquer the drawbacks of spray 
drying technology employing microwave drying. 
Microwave radiation comprises of electromagnetic waves 
with frequencies between the infrared and radio waves, 
which is from the range of 0.3-300 GHz. It passes throughout 
the materials and oscillate their molecules, which usually 
produces heat. Microwave heating may confer several 
advantages above conventional heating, including quick 
heating and cooling, reduced temperature gradients through 
the sample, reduced energy usage, and superior reaction 
rates [28]. 
In Current Study, attempts have been delivered to formulate 
multifunctional pharmaceutical excipients based on Lactose 
Monohydrate and MCC uses Microwave induced diffusion as 
an approach. In existing research authors have engendered 
such system by use of Microwave (MW) irradiation and it is 
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renewable and effective application intended for producing 
molecular dispersions. 
2. MATERIAL AND METHODS 
2.1. Materials 
α -Lactose monohydrate (LM) Ph. Eur., Microcrystalline 
cellulose (MC) and Cellactose was obtained respectively 
from Merck, India, RanQ Pharmaceuticals & Excipients Pvt. 
Ltd, Maharashtra, India, & MEGGLE Excipients & 
Technologies, Germany. Paracetamol and Aspirin were 
obtained as generous gift sample from Glenmark 
Pharmaceuticals, India. 
2.2. Preparation of Multifunctional Composite Particles 
A physical blend of the LM and MC was made by blending LM 
and MC in the specified proportion according to Table 1. 
Perfectly weighed quantity of the LM and MC was then 
passed through the ASTM # 60 sieve. The definite amount of 
distilled water was taken to stainless steel container and 
then slurry was prepared under stirring with the addition of 
a specified quantity of the sifted physical mixture slowly 
(Table 1). Slurry made as per table 1 was then held under 
stirring to obtain a homogeneous dispersion at 1400 RPM 
for a specified span of time to ensure interaction and 
association of LM and MC particles. Slurry was then shifted 
right into a glass beaker thereafter microwaved (Catalyst 2R, 
Catalytic Systems, India.) at 600 W for 4 minutes, mixture 
was then agitated with the help of glass rod. Later it was 
microwaved at 450 W for 5 minutes, resulting aggregates 
were consequently passed through ASTM # 20 and ASTM 
#30 sieves sequentially. Obtained aggregates were again 
microwaved at 200 W to find a moisture content lower than 
5 % w/w. Final aggregates were therefore passed through 
ASTM # 40, 60 and 80. Finally, the mixture was kept in a 
screw-capped bottle until required. 
2.3. Box–Behnken Experimental Design 
Experimental designs are helpful in preparing a formulation 
demanding less experimentation and featuring estimates of 
the relative relevance of numerous variables. This study 
utilized the Box-Behnken model (BBD), a response surface 
methodology, as it needs fewer runs within a 3-factor 
experimental design than all other RSM designs, and is 
particularly beneficial when excessive treatment 
combinations has to be eliminated. Additionally, it helped to 
comprehend the relationship among independent and 
dependent variables in the formulations [29]. Primary 
experiments were conducted to choose the levels of 
excipients that have been evaluated around the mixture's 
capability to constitute the best composite. Three factors 
were identified effect on composite characteristics, those 
factors are Parts of microcrystalline cellulose (X1), Parts of 
Lactose monohydrate (X2) and Mixing time required for 
preparing slurry in Hrs (X3). Initial research likewise 
presented a set-up of the levels for every formulation 
variable. (Table 1). The chosen responses were Angle of 
Repose (Y1), percent fines (Y2), Carr’s Index (Y3), Tablet 
Friability (Y4), Tensile strength (Y5) and Disintegration time 
(Y6). A three-factor three-level Box-Behnken experimental 
design is utilized in the current study to assess the effects of 
chosen independent variables on the responses. This design 
is appropriate for investigation of quadratic response 
surfaces as well as for generating second order polynomial 
models, hence assisting to optimize the process by using a 
small number of experimental runs. A total of 15 
experimental runs designed by BBD is demonstrated in 
Table 1. The design comprises center points with replicates 
and a set of the mid- points of each edge of the 
multidimensional cube. The model features the subsequent 
form: Y = b0 + b1X1 + b2X2 + b3X3 + b4X12 + b5X1X2 + 
b6X1X3 + b7X22 + b8X2X3 + b9X32 + E (1), where Y is the 
selected response, b0–b9 are the regression coefficients, X1, 
X2 and X3 are the factors studied and E is an error term. BBD 
is an orthogonal design; hence, the factor levels are evenly 
spaced. Coding for low, medium and high settings was as −1, 
0 and +1. Subsequent to building the polynomial equations 
relating the dependent and independent factors, the method 
was optimized to uncover the levels of X1, X2 and X3, which 
give optimum values of Y1, Y2, Y3, Y4, and Y5. Box-Behnken 
experimental design. To confirm these values, a new formula 
was set based on the predicted levels of X1, X2 and X3. 
Finally, the obtained responses (Y1, Y2, Y3, Y4, and Y5) were 
assessed and then compared with computed values. A design 
expert software program (Version 8.0.4; Stat-Ease, Inc., MN, 
USA) was used to obtain the design. The software chosen a 
set of candidate points & quadratic model data fitting was 
performed.
 
Table 1: Experimental ranges of independent variables 
Batch Code Run (X1) Microcrystalline 
Cellulose (Parts) 
(X2) 
Lactose Monohydrate (Parts) 
(X3) 
Mixing Time (Parts) 
ML1 1 20 80 30 
ML2 2 30 80 12 
ML3 3 10 80 48 
ML4 4 20 80 30 
ML5 5 30 90 30 
ML6 6 20 70 12 
ML7 7 30 70 30 
ML8 8 20 80 30 
ML9 9 20 90 12 
ML10 10 30 80 48 
ML11 11 20 90 48 
ML12 12 10 70 30 
ML13 13 10 80 12 
ML14 14 10 90 30 
ML15 15 20 70 48 
Variable Level  
 Low High  
Parts of MC (X1) 10 30  
Parts of LM(X2) 70 90  
Mixing Time (X3) 12 48  
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2.4. Evaluation of Microwave generated composites: 
2.4.1. Moisture Content 
A fast infrared moisture analyzer (METTLER TOLEDO, 
Germany) was employed to determine moisture content of 
composite powder accurately. Roughly 1 g of screening 
sample was spread over the disc, and the results were 
recorded after constant reading was displayed. 
2.4.2. Percentage of fines in composites 
Percent fines were calculated considering the percentage 
quantity of composites getting through 200 # (74 μm). A 
definite quantity of the composites was agitated upon an 
Electromagnetic Sieve Shaker (EMS-8, Electrolab, India) 
equipped with 200 # sieve for 5 min. The quantity obtained 
below sieve was calculated as percentage of fines. 
2.4.3. Bulk Density and Tapped density determination 
The bulk and tapped density can be discovered employing a 
tap density apparatus (EDT-1020, Electrolab, India.). 
Defined amount of the test sample (20 g) was placed in a 
measuring cylinder, and the bulk volume is determined. 20 g 
of the material was added to 100 ml measuring cylinder to 
determine tapped density. The observed untapped volume is 
noted. The cylinder is tapped at pre-set drop distance of 14 ± 
2 mm with the rate of 300 drops/min. Following the first 
500 drops, the volume of the material inside the cylinder is 
scored. Furthermore tapping (750 and then 1250 drops 
consecutively) is applied. This final volume is presumed to 
be tapped volume. Bulk/tap densities had been determined 
according to the following equations. 
            (  )   
      
           
     (1) 
              (  )   
      
             
   (2) 
2.4.4. Carr’s Compressibility Index and Hausner’s ratio: 
This represents the percentage of difference between the 
tapped density and the bulk density against tapped density, 
also described as the compressibility index (equations 3). 
Ratio of the tapped to bulk density is expressed as Hausner’s 
ratio (equations 4). Hausner’s ratio ranges from about free-
flowing powder (1.2) to cohesive powders (1.6). Carr's index 
of about 5 - 12% suggest free flowing powder; 23 - 35% 
specify poor flow and extremely poor flow >40% [30]. 
              (
     
  
)                          (3) 
               
  
  
     (4) 
2.4.5. Angle of Repose 
The angle of repose can often be employed to evaluate the 
flow of powders. It is the maximum angle ϴ between the 
plane of the heap of powder and horizontal surface of 
powder heap. The value of ϴ below 30° demonstrates free 
flowing material, up to 40° designates reasonable flow, and 
over 50° suggests distinct difficulty in powder flow. A glass 
funnel was fixed on a stand with height to the tip of the 
funnel was 10 cm from the table surface. 10 g of sample was 
added through the funnel, with a gap of funnel halted up 
with a cotton wool. After removing it a powdered heap was 
formed. The height was assessed as H (cm). Radius, R was 
obtained from the circumference of the heap. The angle of 
repose can be determined applying equation 5 [17]. 
     
 
 
      (5) 
2.4.6. Water absorption ratio (%) 
A piece of multi folded tissue paper was placed into a small 
Petri dish comprising distilled water (10 ml). A tablet was 
placed on the center of the paper, and the time required for 
complete wetting was noted. The water absorption ratio (R) 
was calculated using the following equation. 
                       ( )   
     
  
      (6) 
Where Wb and Wa is the weight of the tablet before water 
absorption after water absorption respectively [31].  
2.4.7. Tablet manufacture 
The composites of batches ML1-ML15 were blended for 5 
min with 2% talc and later 2 min with 1% magnesium 
stearate. Tablets were manufactured using a Rimek rotary 
tablet press with flat-faced punches and dies with a diameter 
of 11 mm (Cadmach Machinery Private Ltd., India).  Average 
tablet weight targeted was 400 mg. Tablet thickness was 
kept ranging between 0.30 to 0.40 cm throughout the 
manufacturing of the tablets. 
2.4.8. Tablet evaluation 
2.4.8.1. Tensile strength 
Tablet dimensions were determined using a micrometre. 
The crushing strength of the tablet was estimated after 24 h 
considering stress relaxation post compression. Erweka 
hardness tester (TBH 125 Series, ERWEKA GmbH, Germany) 
was used to determine crushing strength. The tablet tensile 
strength (MPa) can be calculated using following equation, 
considering crushing strength (P, kg), diameter (D, cm) and 
thickness (L, cm) [32]. 
  
          
    
     (7) 
2.4.8.2. Friability 
Tablet friability was determined by tumbling tablets in a 
friabilator (Model EF2, Electrolab, India) for 4 min at 25 
r/min. The dust was removed from the tablets, friability can 
be calculated as the percent loss in weight of 20 tablets [33]. 
2.4.8.3. Disintegration time 
Disintegration testing was completed according to USP24 
(Model ED2, Electrolab, India). Disintegration of six tablets 
at 37ºC in 900 ml distilled water was observed [34]. 
2.4.8.4. Calculation of composite index 
With the fulfilment of the individual tests a weighted 
composite index was employed to acquire a single score 
implementing two responses, i.e., Carr’s index (%), and 
Friability (%). As it's challenging to estimate the relative 
impact of the individual constraint to the “true” composite 
score, arbitrary value was designated for one-half of each of 
the two response variables. A score 100 for an optimum 
result for each of the two responses was considered. Each 
formulation result was altered to a value between 0 and 50. 
For Carr’s index, allocated lowest and highest value 12.00 
and 40 respectively, with corresponding score 50 and zero. 
Similarly, for friability (%), allocated lowest and highest 
value 0.35 and 1.45 respectively with corresponding score 
50 and zero. The batch with the highest composite index can 
be considered as the batch with desired characteristics. The 
raw data transformations can be done using Equation: 
                                    
       
         
        (8) 
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Where, Yi, Ymax and Ymin are the experimental, maximum 
and minimum values of the individual response, 
correspondingly [35].  
Composite index = transformed value of Carr’s index + 
transformed value of friability (%) (9) 
2.5. Evaluation of optimized composites 
2.5.1. Fourier transform infrared (FTIR) spectral study 
Native excipients LM, MC, physical mixture of LM & MC 
(70:30) and optimized MCLM composites had been taken up 
to evaluate interaction amongst LM and MC using FT-IR 
spectra. Test sample being analysed was mixed up with IR 
grade potassium bromide (KBr) in the ratio of 1:100 and 
compressed utilizing pellet press machine (Kimaya 
engineers, India) applying 15 tons pressure. FT-IR 
spectrophotometer (Shimadzu 8400S, Japan) was used to 
analyse the prepared pellets. Comparison of the principal 
peaks from FT-IR spectra of native excipients, physical 
mixture and optimized composites was done to assess the 
transformation occurred if any. 
2.5.2. Differential scanning calorimetry 
Differential Scanning Calorimetry (DSC) of LM, MC, physical 
mixture of LM & MC (70:30) and optimized MCLM 
composites was performed to assess the changes that had 
actually occurred when MCLM composites were 
manufactured. Differential Scanning Calorimeter (DSC 60, 
Shimadzu, Japan) was used to obtain DSC curves by keeping 
samples in reference pan at a heating rate of 10 °C/min from 
0 to 350 °C in nitrogen atmosphere.  
2.5.3. Determination of particle shape 
Motic (optical) microscope coupled with an Olympus digital 
camera having pre calibrated magnification lenses was 
employed to measure the particle shape in the current 
research. Optimized excipient aggregate was transferred to 
slide and then mounted on the stagecoach. Particle shape 
was determined using 10X magnification lens with built-in 
camera was turned on. Afterwards, the image was captured 
by using Motic Images plus 2.0 software [21]. 
2.5.4. Particle size distribution 
Sieve Shaker (EMS-8, Electrolab, India) was employed to 
determine particle size distribution by sieve size analysis. 
The particle size distribution of optimized composites was 
calculated using a stack of standard sieves with the aperture 
of 149, 125, 106, 90 and 74-μm. A 20 g of the powder sample 
was added on the top sieve and shaker was turned in with 
the speed of 1.50 mm/g for 5 min. The weight of material 
held on each sieve was identified. The mean composite 
diameter was calculated through the percent weight of 
composites retained on each sieve [36]. The average 
diameter can be calculated using the equation:  
                   
 (          ) (              )
   
    (10) 
2.5.5. True density 
The specific gravity (pycnometer) bottle technique was 
utilized for determination of true density, employing acetone 
as displacement fluid. Bottle rinsed with acetone was filled 
to spilled over, excess liquid was wiped away. The weight of 
the bottle loaded with acetone was mentioned as (a), the 
bottle was purged, cleaned and dried. 2 g excipient sample 
was placed into the pycnometer, the weight of the powder 
was mentioned as (w). Pycnometer comprising the 
composite powder was partially filled up with acetone, 
shaken and kept aside for 10 minutes so air bubbles will get 
freed. Finally, pycnometer was filled with acetone and the 
weight of the bottle was noted as (b). True density was 
afterwards calculated as: 
  
 
[(   )  ]
         (11) 
Where ℓ is the particle density of Composite and S is the 
specific gravity of Acetone = 0.786 [37]. 
2.5.6. Determination of tablets packing fraction 
The packing fraction of the tablets can be calculated using 
the particle densities of the tablet formulation. The packing 
fraction, Pf, is determined using the following equation: 
   
 
       
     (12) 
Where W, r, t, l are weight of the tablets, radius, thickness, 
and l is the particle density of tablet using fluid displacement 
method respectively [38]. 
2.5.7. Porosity 
Porosity can be demonstrated as the interarticular space. 
The volume occupied by certain weight of powder is bulk 
volume. Porosity can be calculated using true and bulk 
densities as per following equation [36]. 
        ( )  (
  
 
)          (13) 
Where,    is the bulk density, D is the true density, and e is 
the porosity 
2.5.8. Moisture uptake study 
2 g optimized composites were spread homogeneously on a 
Petri dish (5 cm diameter), and the dish was then stored in 
stability chamber (Newtronic, India) at 40˚C and 75% 
relative humidity. The percent gain in weight was observed 
after 24 h. [36]. 
2.5.9. Loading capacity 
Drug loading capacity of excipient can be explained as the 
minimum concentration at which the excipient can be mixed 
with a drug and the mix keeps the desirable properties of the 
excipient, such as compressibility, flow rate, the ability to 
form hard compacts at low pressures, and so on. Since drug 
loading is among the major constraints of several native 
excipients, drug-loading capacities of Pure excipients LM, 
MC, physical mixture of LM & MC (70:30) and optimized 
MCLM composites were performed. Various ratios of 
paracetamol and each of the excipient mixtures were 
prepared so that each tablet consists of 400 mg paracetamol 
and the excipients. The ratio of paracetamol as to excipient 
was kept as 400:0, 300:100, 200:200, 100:300 and 0:400. 
Powder mixtures were compacted at a compression 
pressure of 25 kN using a single press tablet compression 
machine (Cadmach engineering, Ahmadabad, India.) using 
11.0 mm punch and die set. The punch and die set were pre 
lubricated with a 10 % w/v magnesium stearate dispersion 
in ethanol. The compacts were kept in an airtight glass 
container for 24 h before hardness determination. The 
tablets were tested for hardness using Erweka hardness 
tester (TBH 125 Series, ERWEKA GmbH, Germany.) and 
friability (Model EF2, Electrolab, India). [39]. 
2.5.10. Disintegration efficiency 
The disintegration time for the different aspirin compacts in 
0.1N HCl was determined using a disintegration apparatus 
(Electrolab ED-2L, India) The compacts consist of 300 mg of 
aspirin and 10 % w/w of either excipients from LM, MC, 
physical mixture of LM & MC (70:30) and optimized MCLM 
composites.  Mixing was done in bin blender and tablets 
were compressed using a compression load of 2 MPa 
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employing a rotary tablet press (Cadmach engineering, 
Ahmadabad, India.) with 11.5 mm punch and die. The 
compacts were kept in an airtight glass container for 24 h 
before hardness determination (TBH 125 Series, ERWEKA 
GmbH, Germany) and friability with a friabilator (Model EF2, 
Electrolab, India) [39]. 
2.5.11. Lubricant sensitivity 
The sensitivity of each excipient to lubricant was evaluated 
by using Lubricant sensitivity test (LS). The test was 
performed by mixing powders with magnesium stearate 
(MS) passed earlier through a 250 μm sieve. With all the 
different lubricants being used, magnesium stearate is the 
most widespread exhibit low friction coefficient and high 
covering potential. Lubricant sensitivity analysis was 
conducted by means of the method described by Rojas et al. 
[40] with slight modification. Individual excipient and 1 % 
magnesium stearate were blended using a bin blender 
ranging from 10 to 60 min. After blending, the powder mass 
was screened through ASTM # 30 screen. 400 mg tablets of 
were compressed using rotary press with compaction 
pressure of 70 MPa. Similar method was used to prepare 
tablets without lubricants. Lubricant sensitivity (LS) can be 
calculated using the Equation, 
   
       
  
    (14) 
Where Hlub and Ho are the hardness of the tablets prepared 
with and without lubricants [41]. 
2.5.12. Heckel compressibility analysis.  
Sufficient tablet strength can be accomplished utilizing 
correct ratio of plastic and brittle materials in a tablet 
formulation. Hence Heckel equation is an attractive 
alternative of classifying material. Heckel analysis was 
performed using the equation below, 
  (
 
   
)         (15) 
         (16) 
Where D is the relative density of the compact at pressure P, 
ε is the porosity of powders, and K and A are constants. The 
slope of the Straight line, K is reciprocal of the mean yield 
force, PY of the material and ε is the porosity of a powder 
bed. The Heckel equation represents the relationship of the 
compact density with the applied pressure. The rate of 
density increase with applied pressure is proportional to the 
volume fraction of pores [42]. 
2.5.13. Tablet elastic recovery test 
This study was performed to obtain information about 
elastic recovery during a compression cycle by measuring 
the expansion of the tablet after ejection, thereby to measure 
the whole recovery process, which means the time 
dependency of elastic recovery. Tablets with 400 mg weight 
were manufactured using 11.5 mm die on a tablet press with 
Compression pressure of 200 MPa at the speed of 10 
mm/min. The Elastic Recovery can be calculated by the 
thickness of each tablet under maximum pressure (Hc) and 
after 24 hours from tablet ejection (He) is given by [43], 
    
     
  
          (17) 
After 24 hours of tablet ejection, its weight, diameter, 
thickness and apparent density was determined.  The true 
density (ρt) and tablet porosity (€) was measured with a 
pycnometer. 
  
    
  
      (18) 
2.5.14. The Kawakita analysis  
Packability determination using the Kawakita analysis was 
accomplished. In this technique 10 g of powder was poured 
into a 50 ml glass measuring cylinder. The heaped particles 
inside the cylinder were leveled using scale and the bulk 
volume Vo was noted.  Mechanical tapping was initiated 
afterwards and the difference in volume of the powder Vn 
was noted after N no of taps. The behavior of Pure excipients 
LM, MC. physical mixture of LM & MC (70:30) and optimized 
MCLM composites in the tapping procedure were compared 
using numerical constants obtained from Kawakita plots. 
The information was examined using Kawakita’s [44] and 
Kuno’s [45] equation, 









    (19) 
  
       
  
   
     
  
    (20) 
Where “a” and “b” are constants, n is the number of taps, and 
Vo, Vn, and Vinf are the powder bed volumes initially, after 
nth tapping and at equilibrium, correspondingly. 
      (     ) 
(   )   (21) 
Where ρo, ρn, and ρf, are the apparent densities initially, 
after the nth tapping (5, 10,15, 20, 25, 50, 75, 100) and at 
equilibrium (100th tap) respectively, and k is a constant. 
2.6. Formulation and evaluation of tablets containing 
model drug 
Paracetamol was chosen as a model drug to determine the 
flow, compressibility as well as the tableting behaviour of 
the designed multifunctional excipient. 50 % W/W 
paracetamol, optimized composites and talc (2 % w/w) 
were sifted through # 60 sieve and blended in a bin blender 
for 5 min. Subsequent addition and blending (2 min) with 1 
% w/w Magnesium stearate was done. Obtained blend was 
directly compressed as 400 mg tablet with 10 rotary tablet 
press (Cadmach Machinery Private Ltd., Ahmedabad) using 
11.5 mm dies and punches. The tablets were evaluated for 
weight variation, friability, tensile strength, disintegration 
time, and in-vitro drug release. 
2.6.1. Hardness, Thickness, and Diameter 
Thickness, diameter and hardness of tablets was determined 
using Tablet Hardness Tester (TBH 125 Series, ERWEKA 
GmbH, Germany.) The outcome is the average of 10 
determinations. 
2.6.2. In-vitro drug release 
The in-vitro drug release profile of paracetamol tablets was 
examined using a USP apparatus (model TDT-60T, 
Electrolab, India.) using baskets (50 rpm) with phosphate 
buffer (pH–5.8) as the dissolution medium at 37 ± 0.5ºC. 10 
ml samples were withdrawn at programmed time intervals, 
filtered through a 0.45 μm membrane filter, and assayed at 
243 nm in a UV/vis spectrophotometer (Shimadzu 1601, 
Tokyo, Japan) to build dissolution profile. Fresh dissolution 
medium (10 ml) was added immediately after samples were 
withdrawn. 
2.6.3. Short-term stability study 
The paracetamol tablets were assessed for an accelerated 
stability study. The tablets were kept in a rubber stoppered 
glass vial for 3 months at 40˚C temperature and 75 % 
relative humidity in stability chamber (Newtronic, India). 
The tablets were analysed to access drug release profile at 
specific time interval. 
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3. RESULTS AND DISCUSSION 
3.1. Box–Behnken Experimental Design 
Optimization with factorial designs and evaluation of the 
response surfaces are robust, effective, and organized tools 
that cut short enough time essential for the development of 
pharmaceutical dosage forms and boosts research output. 
Box Behnken (BB) experimental design enables the 
formulator to employ 3 levels of each factor (that has each 
factor positioned amongst each equally spaced value to 
assure orthogonality and near rotatability) to measure 
second-order response models in 15 runs, includes 3-
replicated center points of a cubical design. [46]. BB design 
is known to generate a second-order polynomial model to 
explain the mutual dependency with the examined variables 
[47]. Three primary independent variables which have 
distinctive effects on manufacturing multifunctional 
excipient composites had been uncovered. All these 
important factors consist of Parts of microcrystalline 
cellulose (X1), Parts of Lactose monohydrate (X2) and 
Mixing time in Hrs (X3). As a result, fifteen distinct 
combinations were manufactured, by using the values of the 
major selective variables X1, X2 and X3 at different levels as 
shown in Table 1. Responses for all 15 experimental runs of 
a BB design (ML1-ML15), performed according to Table 1 
are shown in figure 1. Referring to diverse mixtures of 
factors and factor levels, a substantial difference between 
flowability, compressibility and percent fines was observed.
 
































ML1 5.26 17.09 27.41 0.57 0.72 20.69 0.52 2.23 3.97 35.06 64.57 
ML2 5.52 15.18 24.15 0.59 0.77 23.53 0.24 2.60 2.67 57.55 69.41 
ML3 3.79 17.73 30.38 0.57 0.79 28.41 0.79 1.85 4.97 24.07 70.34 
ML4 5.45 16.50 26.57 0.59 0.74 20.00 0.57 2.17 4.10 32.19 77.93 
ML5 5.11 16.41 26.57 0.57 0.70 18.39 0.36 2.70 2.78 54.15 98.59 
ML6 4.28 17.37 25.77 0.59 0.76 22.35 0.52 2.29 3.27 39.70 68.94 
ML7 4.76 11.93 22.48 0.55 0.69 20.88 0.13 2.65 2.52 68.54 65.93 
ML8 4.67 16.00 28.18 0.58 0.74 20.93 0.63 2.19 4.00 34.42 91.66 
ML9 5.24 18.41 28.89 0.59 0.77 23.53 0.75 2.07 3.70 28.66 65.09 
ML10 5.67 13.66 25.02 0.55 0.68 18.68 0.18 2.85 3.05 60.64 69.77 
ML11 4.79 17.56 28.89 0.59 0.76 22.35 0.67 2.07 3.85 31.24 66.49 
ML12 5.73 17.82 32.20 0.62 0.79 22.22 0.75 1.98 4.63 23.32 59.49 
ML13 4.81 18.84 32.74 0.60 0.79 25.00 0.68 1.91 4.45 22.77 75.15 
ML14 5.08 19.40 31.83 0.58 0.77 24.42 0.84 1.62 5.00 20.00 87.67 
ML15 5.18 16.33 26.57 0.57 0.74 21.84 0.39 2.37 3.65 41.36 92.73 
 
3.1.1. Percentage fines 
The mathematical model resulted in for the response Y1 
(Percent Fines) is as follows 
Y1=+16.68-2.08.X1+1.04.X2-0.56.X3 
Figure 1 (A) shows a 3D response surface plot predicted 
through the linear model reveals effect of factor MC (X1), LM 
(X2) and Mixing time (X3) on response percentage fines (Y1). 
As it was constructed with ANOVA values, X1 and X2 factors 
happen to be significant model terms in case of percent fines. 
The amount of fines inside formulation makes a difference to 
flow, compaction, and consolidation. Percentage of fines for 
batches ML1-ML15 are presented in Table 2. The batches 
composed of a low level of MC showed a slightly higher 
percentage of fines than any other batches as a result of 
insufficient binding activity of MC [26]. No batch 
demonstrated fine more than 19.4 %. The limit for fines was 
set at 20 % as an arbitrary requirement for the choice of a 
batch. All the batches fulfilled the selection criteria at the 
three different levels of MC and LM for the percentage of 
fines. 
3.1.2. Angle of Repose, Carr’s Compressibility Index and 
Hausner’s ratio: 
The mathematical model resulted in for the responseY2 






Figure 1 (B) reveals 3D response surface plot predicted 
through the special two factor interaction model shows the 
effect of factor MC (X1), LM (X2) and Mixing time (X3) on 
response Angle of Repose (Y2). ANOVA values implies X1, X2 
and X1X2 interactions are significant model terms in case of 
an angle of repose. Figure 1 (C) reveals 3D response surface 
plot predicted through the special quadratic model explains 
effect of factor MC (X1), LM (X2) and Mixing time (X3) on 
Carr’s Compressibility Index (Y3). X1, X1X2 interaction, X1X3 
interaction, X12 & X32 as significant model terms in case of 
Carr’s index. Table 2 demonstrates flow and compaction 
properties of novel excipient. The angle of repose (θ) implies 
the inter-particulate frictional forces enumerating the 
resistance to powder flow. It was eventually distinguished 
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(Table 2) that the MCLM composites have enhanced flow 
properties than the inherent excipients. Almost all 
composites with a greater amount of microcrystalline 
cellulose demonstrated the lesser angle of repose and good 
to fair compressibility and vice versa. The desirable 
flowability & compressibility of the composites may be due 
to diffused agglomeration of MC and LM particles with 
propinquity of water in the microwave [28]. From Table 2, it 
could be observed that a microwaving process, resulting in 
near spherical particles, reduces the time required for the 
mass-flow of a given sample volume, thereby increasing the 
flow rate. LM alone display brittle fracture addressing poor 
compressibility while microcrystalline cellulose is actually a 
plastic material demonstrating good compressibility. The 
better compressibility from the composites might be caused 
by a coating of MC over LM particles with the presence of 
water in the microwave. This shows that microwave 
generated co-processed excipients are effective within the 
manufacturing of novel excipients with enhanced flowability 
[21]. 
3.1.3. Friability 
The mathematical model generated for the responses Y4 
(Friability) is as follows, 
Y4=0.53-0.27X1+0.10.X2-0.02.X3 
Figure 1 (D) displays a 3D response surface plot predicted 
through the special two factor interaction model reveals 
effect of factor MC (X1), LM (X2) and Mixing time (X3) on 
response percent friability (Y4). As it was constructed from 
ANOVA values, X1 and X2 factors are significant model terms 
in the event of friability. Disproportionate friability is 
unacceptable as, crumbling and dusting of the tablets lead to 
loss of the active ingredients, influences the tablet 
appearance and consumer appeal, and decreases the potency 
of any tablet. It could be ascribed by a range of factors like 
poor tablet design (too sharp edges), low moisture content, 
insufficient binder, etc. The friability of tablets reduced by 
the augmented amount of microcrystalline cellulose. This 
could be resulting from good binding properties of 
microcrystalline cellulose. Mixing time for preparing 
excipient composites likewise have vital effect as a model 
term, this suggests increased mixing time will allow good 
association of MC and LM particles and therefore composites 
with better resistance from friability. 
3.1.4. Tensile strength 
The mathematical model generated for the responses Y5 
(Tensile strength) is as follows 
Y5=2.24+0.43.X1-0. 104.X2+0. 031.X3+0. 10X1.X2+0.08.X1.X3-0. 
02X2.X3 
Figure 1 (E) displays a 3D response surface plot predicted 
from the special two factor interaction model shows the 
effect of factor MC (X1), LM (X2) and Mixing time (X3) on 
response percent tensile strength (Y5). An ANOVA values 
show X1, X2, X1X2 interaction and X1X3 interaction factors 
are significant model terms in the instance of tensile strength 
of tablets. Tablet strength is a vital property for patient 
handling, innocuous transportation and coating of tablets in 
a coating machine. The tensile strength of the tablets 
increased with increased mass of MC as well as LM. ANNOVA 
values implies prevalent impact of MC on tensile strength of 
tablets. This trend can be depicted through interfacial 
interaction of the particles. Edge et. al. [48] and van Veen et 
al. [49] discovered that the tensile strength improvement by 
physical modification of microcrystalline cellulose properties 
might be due to interfacial interaction instead of 
modification of bulk MC properties. Mixing time for 
preparing excipient composites likewise have a significant 
effect as a model term, this suggests increased mixing time 
allows good association of MC and LM particles and therefore 
composites with enhanced tensile strength. All experimental 
trials have demonstrated tensile strength ranging from 1.61 
to 2.84 MPa. These outcomes suggested the fact that amount 
of MC played a substantial role within the manufacturing of 
satisfactory composites by the microwave-induced diffusion. 
3.1.5. Disintegration time & water absorption ratio 
The mathematical model generated for the responses Y6 
(Disintegration time) is as follows 
Y6=+4.02-1.X1+0.16.X2+0.18.X3-0.03.X1.X2-0.03.X1.X3-
0.06.X2.X3-0.06.X1²-0.23.X2²-0.18.X3²  
Figure 1 (F) displays a 3D response surface plot predicted 
through the special cubic model shows the effect of factor MC 
(X1), LM (X2) and Mixing time (X3) on response 
disintegration time (Y6).  ANOVA values indicate X1, X2, X3, 
X22 & X32 factors are significant model terms in the event of 
disintegration time of tablets. Disintegration time for tablets 
manufactured using composites was supposed to be less 
than 15 minutes. All experimental trials from ML1 to ML15 
have demonstrated disintegration time below 298 seconds. 
Tablets of batches ML2, ML5 and ML7 demonstrated 
disintegration time less than 180 seconds. The effect of the 
increased percentage of MC, LM and Mixing time (HR) on the 
disintegration time of the tablets was identified significantly. 
While using the composition of MIND generated 
multifunctional cellulose lactose excipient, cellulose 
disintegration simply begins following the dissolution of the 
outer layer of lactose; allowing rise to aqueous solutions of 
significant viscosity, which in turn prevents water entry to 
the cellulose nucleus. As the lactose covers the cellulose 
fibers, moisture sorption is significantly lower than 
microcrystalline cellulose alone. The combination of lactose 
and cellulose may merge good water absorption and 
disintegration properties of cellulose with the good 
flowability and the solubility of the lactose [50]. Mixing time 
for preparing excipient composites also have a significant 
effect as a model term, this indicates increased mixing time 
allows good association of MC and LM particles and hence 
composites with better disintegration time. 
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Figure 1: Response surface plots for (A) Percent Fines (B) Angle of Repose (C) Carr’s Index (D) Tablet Friability (E) Tensile 
strength (F) Disintegration Time 
 
Table 3: Regression output for Box – Behnken Design for batches (ML1 to ML15) 








R2 0.97 0.97 0.85 0.92 0.98 0.99 
Adjusted R2 0.94 0.92 0.82 0.89 0.96 0.98 
P 0.0001 0.0280 0.0001 0.0001 0.0001 0.0001 
 
3.2. Design optimization results 
The six responses were plotted together by means of 
statease design expert software to evaluate a standard 
optimal region. The factors X1, X2 & X3 at 30 parts, 70 parts 
and 45.813 Hrs. correspondingly offered the optimum 
response of Y1: 13.07 %, Y2:22.77, Y3:19.84, Y4: 0.143%, 
Y5:2.782 mPa Y6:2.638 min. The mathematical model was 
evaluated by designing the optimized composite formulation 
conforming to aforementioned factor levels to establish the 
trustworthiness of the model. The percentage prediction 
error was found lower for Y1 to Y6 (Table 4) illustrates the 
robustness of the mathematical model and high prediction 
ability of the experimental design. 
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Table 4: Experimental and Predicted Values for the Optimized MCLM Composites 
Response Experimental 
valuea 
Predicted value Percent 
prediction errorb 
Y1 13.68±0.37 13.07 4.47 
Y2 23.40±0.91 22.77 2.68 
Y3 20.67±0.44 19.84 4.01 
Y4 0.133±0.01 0.14 7.73 
Y5 2.692±0.09 2.78 3.36 
Y6 2.761±0.05 2.64 4.46 
a Mean of 3±SD          b Percentage error was calculated using the formula [(Experimental value−Predicted value)/Experimental value] ×100  
3.3. Moisture Content 
Moisture content impact the physico-chemical and then 
microbiological properties of finished pharmaceutical goods. 
Optimum moisture content of excipient is accountable to 
good flowability and compressibility. The composites of 
batch ML1 to ML15 exhibited a moisture content between 
3.79 to 5.73 % which was found optimum. All composites 
show considerably less moisture content as sufficient drying 
occurs in the microwave. The higher moisture content could 
possibly be a result of the normal water content of α-lactose 
monohydrate which is around 5%.  
3.4. Calculation of composite index 
All experimental batches fulfilled the decision criteria set for 
angle of repose and Carr’s index. Composite index near to 
100 signifies the appropriateness of composition in terms of 
flow and compaction. The outcomes of composite index are 
demonstrated in Table 2, illustrates the highest index value 
of 98.59, 92.73 and 91.66 for batches ML5, NL15 and ML8 
correspondingly. The index value indicates higher content of 
MC and mixing time is responsible for good flow and 
compressibility properties. 
3.5. Characterization of optimized batch 
3.5.1. Fourier transform infrared (FTIR) spectral study 
FT-IR spectroscopy facilitates identifying compounds by 
simple and quick technique. The IR spectrums of a given 
substance are unique and characteristic. IR spectrum can 
differentiate different types of bonds and help to get 
knowledge about structural changes and the interaction 
between the molecules. The IR spectra of MC, LM, Physical 
mixture of MC and LM (70:30) and MCLM Composites are 
presented in Figure 2. MC displays characteristic peaks at 
3446 cm-1 (O-H stretching), 1431 cm-1 (intramolecular 
hydrogen bonds of the C6 group and O-H in-plane bending 
vibration), and 889 cm-1 (antisymmetric out-of-phase 
stretching vibration) [35]. The peaks of hydroxyl (O-H) and 
aromatic (C-C) groups of lactose monohydrate were found at 
3389 and 1562 cm−1, respectively.  Similar characteristic 
peaks were observed in both the physical mixture and 
optimized MCLM composites suggesting no chemical 
alteration of interaction has occurred during processing and 
physical mixing. The presence of some additional functional 
groups at 784 cm-1 compared to that of MC and LM against 
MCLM composites suggests physical modification of native 
excipient took place during microwave drying. 
3.5.2. Differential scanning calorimetry 
DSC is a beneficial technique of explaining polymers 
depending on their thermal transitions which can be 
endothermic or exothermic. DSC thermogram of any 
compound exhibits first endothermic peak known as glass 
transition (Tg) & and second endothermic peak as melting 
(Tm) temperature which can be easily identified in any 
endotherm. The DSC thermograms of MC, LM, Physical 
mixture of MC and LM and MCLM composites are manifested 
in Figure 3. In DSC of LM desolvation endotherm is evident in 
the 140-160° C region, melting endotherm at somewhere 
around 217°C and small decomposition endothermic peak at 
225°C, while in case of MC melting endotherm was detected 
at 230°C. Identical endothermic peaks were observed in 
optimized MCLM composites at 219 °C indicating no 
chemical modification has happened during the microwaving 
process.  Investigation of thermograms of the MC, LM and the 
composite signifies little shifting of melting endotherm 
implies physical combination of MC and LM mixtures 
yielding novel functional composite excipient. 
 
 
Figure 2: FT- IR Spectrum of (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and MC 
(70:30) (D) Optimized MCLM Composites 
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Figure 3: DSC of (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and MC (70:30) (D) 
Optimized MCLM Composites 
3.5.3. Determination of particle shape 
Photomicrographs captured in the Motic software package 
for optimized composite excipient are embodied in Figure 4. 
From photomicrographs particle shape was observed to be 
elongated to asymmetrically spherical. Particle size 
determined employing image pro software was found in a 
range of 80 to 174 µm. Based on the spherical shape 
observed for MCLM composites are expected to flow freely 
dues to elongated and near spherical shape. 
 
 
Figure 4: Photomicrographs of Optimized MCLM composites at 10X 
 
3.5.4. Particle size distribution 
Optimum amount of fines in powder blends for direct 
compression is a key factor as it may lead to segregation 
which will results in poor powder homogeneity yielding 
weight variation of tablets. All of the composites of batch 
ML1 to ML15 and optimized composites passed through an 
ASTM # 80 (180 μm) sieve during particle size distribution 
estimation using sieve analysis. Whereas not more than 3 % 
of agglomerates were retained on an ASTM # 200 (74 μm) 
sieve. The optimized composites demonstrated mean 
particle size 92.86±0.37 μm. This elaborates better particle 
size distribution profile with optimum fines suggesting best 
fit for achieving good blend and content uniformity during 
tablet manufacturing [28]. 
3.5.5. True density and Porosity 
Compaction of powders right into a tablet is a means of 
reducing porosity into a solid compact. The powder structure 
changes, especially during compression as densification 
occurs primarily as a result of rearrangements of particles, 
their fragmentation and plastic deformation. Higher porosity 
quickens the degree of deformation of excipients during the 
compression and then enhances the tensile strength of the 
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manufactured tablets. [20].  The composites of batch ML1 to 
ML15 and optimized composites exhibited true density 
between 1.42 to 1.55 and porosity varying through 24.71 % 
to 32.23 %. True density of physical mixture of LM & MC, 
cellactose and optimized composites was found to be 
1.53,1.57 and 1.42 respectively, while porosity was found to 
be 24.98, 39.49 and 30.68 respectively. The porosity of co 
processed excipients was found higher, which may be due to 
physical modification done using spray and microwave 
drying as they generate porous particles. Effect of porosity 
on tablet compressibility can be well discussed using 
Kawakita and Kuno’s equation in further discussions. 
3.5.6. Moisture uptake study 
Moisture content of excipients is a key factor that may alter 
physical, chemical and microbiological properties of 
formulation and ultimately quality of final product. Optimum 
moisture content in excipient is necessary for better 
compressibility properties. Immediately after 24 h storage at 
40˚C temperature and 75 % relative humidity, composites of 
batch ML1 to ML15 exhibited moisture uptake between 5 to 
18 %, it was observed that moisture uptake capacity elevated 
with increased quantity of MC as it possesses moisture 
uptake properties [13]. Optimized composites adsorbed 
4.99±0.77% w/w moisture demonstrating poor moisture 
sensitivity of optimized composites indicating use of 
excipient to formulate better physical, chemical and 
microbiological quality attributes.  
3.5.7. Loading capacity 
Loading capacity is recognized as important property of 
directly compressible materials. The MCLM composites, MC, 
LM, physical mixture of LM and MC (70:30) and cellactose 
were subjected for loading capacity determination. A model 
drug selected for the loading capacity determination was 
Paracetamol (PAR) owing to its poor compaction property & 
its capability to undergo a considerable elastic recovery as an 
when compaction pressure is withdrawn [51]. Loading 
capacity implies the amount of drug which can be appended 
in formulation. The larger the loading capacity, higher the 
quantity of drug that can be appended. Figure 5 illustrates 
the increased hardness with increased excipient ratio in 
accordance with that of PAR in the compacts. Compacts 
manufactured with all excipients demonstrated similar 
hardness attributes with ratio of P300: E100 (Figure 5). MC 
compacts had highest hardness followed by optimized 
composites and cellactose at the varying ratio after P300: 
E100.  Higher loading capacity of MC can be correlated 
perfectly with porosity. Blends with MCLM composites 
offered lower values of hardness than blends with MC when 
the paracetamol percentage was below 50%. Optimized 
MCLM composites demonstrated better hardness profile 
than cellactose. In this instance, the best excipient was 
defined as the one which, when mixed with paracetamol, was 
significantly less influenced in its flow and compactability 
properties. These conditions are best achieved by Optimized 
MCLM composites. Bulk and tapped densities of excipients 
demonstrated inverse relationship with the powder’s loading 
capacity. The loading capacity of the various excipients as 
examined by the compact hardness of equal excipient and 
PAR mixture can be sequenced as follows (MC > MCLM 
optimized composites > Cellactose >LM>Physical Mixture).
 
 
Figure 5: Loading capacity of (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and MC 
(70:30) (D) Optimized MCLM Composites (E) Cellactose 
3.5.8. Disintegration efficiency 
The objective of analyzing disintegration efficiency was to 
assess the disintegration behavior of newly formed excipient 
without disintergrant. The disintegration time of aspirin 
tablets manufactured with MC, LM, Physical Mixture of MC & 
LM (30:70), MCLM composites and cellactose are shown in 
Figure 6. A model drug chosen for study was aspirin due to 
its low solubility in water and good compatibility. The 
compressed aspirin without excipient and with MC 
disintegrate after 2 hr. in contrast physical mixture exhibited 
disintegration time of (26.29±1.83 Min). Aspirin compacts 
manufactured with MCLM composites and cellactose 
disintegrated within 15 min, which is much shorter 
disintegration time than MC compacts. Numerous 
mechanisms have been extended for the mechanism of 
disintegrants including swelling, deformation recovery and 
water wicking. The disintegrant capability of MCLM 
composites has been credited largely to water wicking and 
deformation recovery [52]. The results imply application of 
MCLM composites as excipient for peroral tablets in 
accordance with those developed with MC and LM 
considering disintegration. 
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Figure 6: Disintegrant Efficiency of (A) Lactose 
monohydrate (B) Microcrystalline Cellulose (C) Physical 
Mixture of LM and MC (70:30) (D) Optimized MCLM 
Composites (E) Cellactose 
3.5.9. Lubricant sensitivity 
Lubricants, when included in a small amount among two 
contacting or rubbing surfaces, reduce interfacial friction. It 
is well discovered that a large number of excipients in binary 
excipient drug mixtures reveals better compactability 
devoid of lubricants. If similar structure is augmented with 
the magnesium stearate, distinctive decrease of hardness is 
observed with the same compacting pressure. This change 
might be attributed to decrease in adhesion. It is familiarized 
that prolonged mixing of magnesium stearate with 
agglomerates generate a film over the agglomerates and 
prevent binding of agglomerates [63]. Materials with plastic 
deformation possess more sensitivity than with brittle 
fracture deformation. The lubricant sensitivity reflects 
capacity of the material to mix with lubricant; the higher the 
ratio, the greater the ability to mix with a lubricant. The 
mixing time is an essential element that influences tensile 
strength [35]. From the results it is evident that prolonged 
mixing of magnesium stearate lowered the tablet hardness. 
MCLM composites express slight sensitivity to the Mg 
Stearate. Presence of lubricant has insignificant influence on 
the consolidation of MCLM composites since the fragmenting 
behavior predominates plenty of fresh surfaces of lactose 
are produced under compression and, therefore, the effect of 
the lubricant would be at a minimum. Figure 7 illustrates the 
profile for lubricant sensitivity ranged as Physical 
Mixture>LM>MC>Optimized MCLM composites>Cellactose. 
Figure 7 symbolizes the effect of blending time on lubricant 
sensitivity. Lubricant sensitivity within 30 min of blending 
for Optimized MCLM composites and cellactose implies that 
newly available sites for particle binding are created soon 
after 30 min. Amongst all compositions highest sensitivity 
has been demonstrated by a physical mixture, indicating 




Figure 7: Lubricant Sensitivity of (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and MC 
(70:30) (D) Optimized MCLM Composites (E) Cellactose 
3.5.10. Tablet elastic recovery test 
Table 5 elaborates the outcomes of tablet elastic recovery 
(ER) tests. ER was found elevated in compacts with physical 
mixture, MC and LM while significantly less for optimized 
composites and cellactose. Elasticity property of the compact 
particles is reflected by ER. The high ER value represents a 
decline in tablet strength as a result of reduction in bonding 
surface area contributing to capping and lamination of 
tablets. The particle interaction affects the relaxation 
behavior of tablets. Tablet relaxation is usually regarded as 
an excellent balance concerning stored elastic energy as the 
key force of expansion and particle bonding as counteracting 
force [54].  LM and physical mixture represents highest 
elastic recovery, which may be due to higher particle size, 
crystallinity and the degree of disorder of LM particles [55]. 
MC represents the higher elastic recovery owing to its 
elongated shape and hydrophobic surfaces of MC, that could 
be resisting particle densification and interparticle bonding 
[56]. The lowest ER of MCLM and Cellactose tablets reflected 
higher inter-particulate bonding between particles masking 
hydrophobic surfaces of MC by hydrophilic surfaces of LM. It 
is trustworthy to note that elastic recovery properties of MC, 
LM and physical mixture of MC and LM are masked 
completely in optimized composites. The elastic recovery 
expressed by MC in present research work is overcome by 
hydrophilic properties of LM suggesting functional use of co 
processing MC and LM by microwave drying which LM 
covers MC particles in composite aggregates. ER results of 
optimized MCLM composites implies its use as directly 
compressible material with multifunctional properties.   
3.5.11. Determination of tablets packing fraction 
Table 5 shows the outcomes of Packing fraction. The packing 
fraction, demonstrates the degree of consolidation of the 
tablet after compaction. The packing fraction was observed 
to be best for optimized MCLM composites followed by 
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cellactose indicating denser particles in bulk. Tensile 
strength value facilitates the outcomes of packing fraction, 
signifying reduction of voids between particles at the highest 
pressure [57]. Consequently, optimized MCLM composites 
should be considered for greater consolidation. 
 
Table 5 – Diameter, Height, Elastic Recovery and packing fraction of LM, MC, Physical Mixture of LM & MC (70:30) and 
Optimized MCLM Composites. 








LM 11.5 3.07 27.69 0.81 
MC 11.5 2.46 21.54 1.02 
Physical Mixture (LM+MC) 11.5 3.02 25.50 0.85 
Cellactose 11.5 3.09 2.59 0.90 
Optimized MCLM Composites 11.5 3.19 3.97 0.77 
 
3.5.12. Heckel compressibility analysis.  
The Heckel equation represents the relationship between 
compact density & applied pressure. The rate of density rise 
with the applied pressure is proportionate to the volume 
fraction of pores [42].  Mean yield pressure (Py=1/K) can be 
represented by the reciprocal value of the slope implies 
attribute of aggregates that resists the deformation. Heckel 
plot explains several phases of the compression process. The 
most crucial curvature point implies the particle 
rearrangement prior to a plastic deformation commences. A 
linear part in the plot symbolizes plastic deformation and a 
plateau is reached. The plateau is identified through the 
work of hardening and crystal density change. This section of 
Heckel plot also designates the elastic deformation of the 
powder mass [35]. The constants for Heckel equation are 
listed in Table 6. The Heckel plots of the powder mixtures 
evaluated are demonstrated in Figure 8 display rank order 
for Py values as MC>Physical Mixture> 
LM>Cellactose>Optimized MCLM Composites. This implies 
the fact that beginning of plastic deformation is a lot faster in 
the native excipients than the MCLM Composites and 
cellactose. Usually, a smaller Py value demonstrates higher 
plastic deformation, low resistance to compaction pressure, 
better densification and easy compression. In low 
compaction pressure removal of voids associated with the 
loose particles results through rearrangement, 
fragmentation and plastic deformation, resulting in quick 
densification of optimized MCLM composites. However, the 
second phase (1 to 3 Ton pressure) contributes to plastic 
deformation of MCLM composite particles accountable for 
the densification of MCLM compact. Third phase (3 to 6 Ton 
pressure) subsequent to decompression, a gain in tablet 
height is depicted by elevated tablet porosity. The 
compactibility of optimized MCLM composites is attributed 
to a synergistic effect of consolidation by fragmentation of 
lactose and plastic deformation of cellulose, although the 
identical effect is not observed in physical mixture 
suggesting demand of processing over native excipient [53]. 
The physical mixture marginally improves the particle 
rearrangement at primary phase of the powder bed 
densification. LM mainly deforms by brittle deformation, and 
MC is deemed slightly elastic in nature. 
  
 
Figure 8: Heckle Plots for (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and MC (70:30) 
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Table 6: Heckle, Kawatika and Kuno’s parameters for LM, MC, Physical Mixture of LM & MC (70:30) and Optimized MCLM 
Composites. 
Material Kawatika Kuno Heckle 
a b K Consolidation 
index 
A K Py 
LM 0.35 0.04 0.42 -1.49 0.38 1.11 2.63 
MC 0.30 0.05 0.38 -1.72 0.33 0.87 3.07 
Physical Mixture (LM+MC) 0.47 0.03 0.59 -1.75 0.37 0.77 2.70 
Cellactose 0.25 0.04 0.36 -1.75 0.42 0.86 2.38 
Optimized MCLM Composites 0.20 0.05 0.35 -1.65 0.47 1.13 2.13 
 
3.5.13. The Kawakita analysis  
The Kawakita equation proposes that N/C is proportional to 
the number of taps. Figure 9 displays the plot of a N/C vs 
number of taps for MC, LM, Physical Mixture, Cellactose and 
optimized MCLM composites. One can notice that a linear 
relationship prevails between N/C and the number of taps in 
the whole pressure range investigated at a correlation 
coefficient (R2 = 0.934), signifies that densification behavior 
is in line with conjecture from the Kawakita equations. Table 
6 displays the values of a, i.e. the maximum volume 
reduction after tapping. The rank order of ‘‘a’’ is Physical 
Mixture>LM>MC>Cellactose>MCLM optimized Composites. 
It could be noticed that with a smaller number of tapping 
MCLM tablet is way better packed than Cellactose before 
initial tapping into the cylinder. Low ‘‘a’’ value implies the 
fact that tapping reduces voids by air displacement through 
the powder bed, devoid alteration of particle size and shape. 
This might be caused by lowering densification brought on 
by forming considerably more void spaces between particles 
by MIND diffusion [21]. Furthermore, the “a” parameter as 
well as the total powder porosity were found comparable. 
The “b” value analysis has been associated with cohesion 
and various other types of particle interaction forces. The 
higher “b” parameter attained implies a low degree of 
interparticle interactions that oppose volume reduction, and 
therefore, such material was the easiest to compress 
(volume reduction) by applied tapping. The “b” value of the 
optimized MCLM and cellactose (0.05) proved that the 
packing velocity of the MCLM composites was quick than 
that of LM and MC powder, this is supported by smaller “K” 
value of Kuno’s equation (Table 6). The slow packing 
velocity is proportionate to powder bed consolidation per 
tap. Consequently, from enhanced packability, optimized 
composites exhibited better compression in contrast to LM 
and MC powder [35]. The results of Kawakita and Kuno’s 
analysis suggests quicker consolidation of MCLM composites 




Figure 9: Modified Kawakita Plots of (A) Lactose monohydrate (B) Microcrystalline Cellulose (C) Physical Mixture of LM and 
MC (70:30) (D) Optimized MCLM Composites (E) Cellactose 
3.6. Formulation and evaluation of tablets containing 
model drug 
Table 7 shows that the composites of optimized MCLM 
composites presented satisfactory tableting characteristics 
with paracetamol. The model drug formulation 
demonstrated weight variations < 5%, friability < 1%, and a 
disintegration time < 17 min. An in-vitro drug release profile 
of paracetamol tablets prepared with optimized MCLM 
composites in contrast to the market formulation (Glaxo 
SmithKline Pharmaceuticals Ltd) found comparable. The in-
vitro drug release profiles of marketed and test formulation 
are displayed in Figure 10. Tablets manufactured with 
optimized MCLM composites demonstrating similarity factor 
more than 80 with marketed formulation. 
Table 7: Percentage composition of the tablets using model 
drug. 
Ingredients/parameters  
Paracetamol (%) 50 
Optimized MCLM composites (%) 48 
Talc (%) 1 
Magnesium stearate (%) 1 
Average weight (mg) 404.6±4.64 
Tablet hardness (N) 86±4.16 
Friability (%) 0.47 
Disintegration time (min) 11.00±1.74 
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Figure 10: In Vitro Drug release of tablets with Optimized MCLM Composites and Marketed formulation. 
3.7. Short-term stability study 
Tablets comprising paracetamol were subjected to 
accelerated stability testing (3 months, 45˚C/75% RH). The 
f1 value was less than 10 and the f2 value [24] was greater 
than 80 for the drug release profile of formulations before 
and after the stability study. 
4. CONCLUSION 
Microwave induced diffusion technology for Co processing 
was used in the form of particle engineering technique to 
enhance the functionality of Lactose monohydrate and 
Microcrystalline cellulose in the formulation of direct 
compression tablets. Optimized composition of this co-
processed excipient was determined using Box Behnken 
Design of Experiment (DoE) by identifying the proportion by 
percentage weight of all the elements used in co-processing. 
The optimized formula for manufacturing the 
multifunctional excipient MCLM composites was established 
being lactose monohydrate (70 %), and microcrystalline 
cellulose (30 %) correspondingly.  The Microwave induced 
diffusion method has been discovered to become a potential 
substitute technique to manufacture directly compressible 
multifunctional excipients. Resulting MCLM composites has 
demonstrated low percentage of fines, moderately 
hygroscopic and compatible with the drug of choice for the 
study. Flow and compaction characteristics of MCLM 
composites were improved in comparison with lactose 
monohydrate and the physical mixture of LM and MC. There 
was a marked improvement in the compressibility, 
tabletability and compactibility (CTC) profile of MCLM as 
compared with the physical mixture of the constituent 
excipients.  Carr’s index, friability, tensile strength, 
disintegration time and the composite index, the optimized 
batch comprising MC (30%), LM (70 %) was found optimum. 
Kawakita and Kuno parameters advise higher efficiency of 
the optimized MCLM than MC, LM and the physical mixture 
having the same composition. Heckel analysis revealed the 
fact that agglomerates undergo plastic deformation in 
comparison with MC, LM and also the physical mixture. The 
agglomerates exhibited an acceptable dilution potential. 
From the outcomes of this research, it can be concluded that 
co-processed excipients obtained from microcrystalline 
cellulose and lactose can be utilized as potential 
multifunctional directly compressible excipients. The 
Microwave Induced Diffusion technique is identified 
beneficial as normally requires short processing time, which 
can be, an advantage over spray-drying. Resulting 
multifunctional excipient presents decent content uniformity 
as a result of the low segregation tendency, good compaction 
and flow properties, steady hardness and high weight 
uniformity at all compaction speeds. 
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